BT200

DB18333Investigational

BT200 (Rondoraptivon pegol) is a PEGylated anti-von Willebrand factor (VWF) aptamer targeted against the VWF A1 domain. It is under investigation for the treatment of von Willebrand disease and hemophilia...

Mechanism: Pharmacologically active on von Willebrand factor
Curator reviewed
Also known as: Rondoraptivon pegol
Code names: BT-200

Resolves to

Compound

UNIIYD6HJ2PE4Q

Targets

P04275VWF

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with BT200, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account